The Programme Office is led by the Executive Director, who is responsible for the day-to-day management of the Innovative Medicines Initiative (IMI).
The Programme Office executes the decisions of the Governing Board and responds to information requests from the Governing Board, the Scientific Committee, and the States Representatives Group. The activities of the Programme Office include:
- organising the regular Calls for proposals and the selection of the research consortia that will receive IMI funding,
- managing the public and private funding and
- organising communication regarding IMI.
The Programme Office's full list of tasks is set out in the legislation creating IMI
Download the IMI Programme Office Organisational Chart
Contact the Programme Office.